Talis Biomedical Corp Quarterly Operating Lease, Payments in USD from Q2 2021 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Talis Biomedical Corp annual/quarterly Operating Lease, Payments history and growth rate from Q2 2021 to Q3 2022.
  • Talis Biomedical Corp Operating Lease, Payments for the quarter ending September 30, 2022 was $343K, a 18.7% increase year-over-year.
  • Talis Biomedical Corp annual Operating Lease, Payments for 2023 was $3.97M, a 192% increase from 2022.
  • Talis Biomedical Corp annual Operating Lease, Payments for 2022 was $1.36M, a 29.5% increase from 2021.
  • Talis Biomedical Corp annual Operating Lease, Payments for 2021 was $1.05M, a 29.5% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $343K +$54K +18.7% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $322K +$61K +23.4% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-02
Q3 2021 $289K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $261K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.